Xipamid-ratiopharm may be available in the countries listed below.
Ingredient matches for Xipamid-ratiopharm
Xipamide is reported as an ingredient of Xipamid-ratiopharm in the following countries:
- Germany
International Drug Name Search
Xipamid-ratiopharm may be available in the countries listed below.
Xipamide is reported as an ingredient of Xipamid-ratiopharm in the following countries:
International Drug Name Search
Princimox may be available in the countries listed below.
Amoxicillin is reported as an ingredient of Princimox in the following countries:
International Drug Name Search
Oxalisin may be available in the countries listed below.
Oxaliplatin is reported as an ingredient of Oxalisin in the following countries:
International Drug Name Search
Alplax may be available in the countries listed below.
Alprazolam is reported as an ingredient of Alplax in the following countries:
International Drug Name Search
Histodil may be available in the countries listed below.
Cimetidine is reported as an ingredient of Histodil in the following countries:
International Drug Name Search
Lebersdan may be available in the countries listed below.
Protoporphyrin Disodium is reported as an ingredient of Lebersdan in the following countries:
International Drug Name Search
Generic Name: ranitidine bismuth citrate (ra NYE te deen bizz MUTH SI trate)
Brand Names: Tritec
Ranitidine bismuth citrate was withdrawn from the U.S. market in 1998.
Ranitidine is in a class of drugs called histamine receptor antagonists. Ranitidine works by decreasing the amount of acid your stomach produces.
Bismuth is a mild antibiotic.
Citrate is a form of salt.
Ranitidine bismuth citrate is used to decrease the amount of acid in the stomach and to treat Helicobacter pylori, a bacterial infection involved in causing stomach ulcers. Ranitidine bismuth citrate is most commonly used with clarithromycin (Biaxin), an antibiotic, to treat this infection.
Ranitidine bismuth citrate may also be used for conditions other than those listed in this medication guide.
Ranitidine bismuth citrate was withdrawn from the U.S. market in 1998.
Before taking this medication, tell your doctor if you have
liver disease; or
acute porphyria.
You may not be able to take ranitidine bismuth citrate, or you may require a lower dose or special monitoring during treatment if you have any of the conditions listed above.
Take ranitidine bismuth citrate exactly as directed by your doctor. If you do not understand these instructions, ask your pharmacist, nurse, or doctor to explain them to you.
Ranitidine bismuth citrate is usually taken twice a day (every 12 hours) for 4 weeks. You will probably also take the antibiotic clarithromycin (Biaxin) three times a day for the first 2 weeks of therapy. Follow your doctor's instructions.
See also: Ranitidine bismuth citrate dosage (in more detail)
Take the missed dose as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and take only your next regularly scheduled dose. Do not take a double dose of this medication unless otherwise directed by your doctor.
Symptoms of a ranitidine bismuth citrate overdose are not known but might include nausea, vomiting, diarrhea, increased saliva production, shaking, difficulty breathing, and a fast heartbeat.
There are no restrictions on food, beverages, or activity while taking ranitidine bismuth citrate unless your doctor directs otherwise.
Other, less serious side effects may be more likely to occur. Continue to take ranitidine bismuth citrate and talk to your doctor if you experience
changes in taste;
headache or dizziness;
diarrhea, nausea, or constipation; or
tremor (shaking).
Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome.
Usual Adult Dose for Duodenal Ulcer:
Ranitidine bismuth citrate was voluntarily withdrawn from the US market by the manufacturer in 1998. The following dosage information applies to when the drug was available in the U.S. Also, treatment guidelines issued by the American College of Gastroenterology no longer include dual-therapy.
Associated with H. Pylori: 400 mg orally twice a day for 28 days.
Before taking ranitidine bismuth citrate, tell your doctor if you are taking any of the following medicines:
Sedatives, sleeping pills, or tranquilizers such as alprazolam (Xanax), diazepam (Valium), and chlordiazepoxide (Librium) may cause dangerous sedation when taken with ranitidine bismuth citrate.
Anticoagulants (blood thinners) such as warfarin (Coumadin) may have increased effects, which could result in bleeding.
Seizure medications such as phenytoin (Dilantin) and carbamazepine (Tegretol) may have dangerous side effects when taken with ranitidine bismuth citrate.
Medications for heart disorders, such as procainamide (Procanbid, Procan SR, Pronestyl), propranolol (Inderal), and metoprolol (Lopressor), may have increased effects on your heart when you are taking ranitidine bismuth citrate.
Oral diabetes drugs such as glipizide (Glucotrol), glyburide (Diabeta, Micronase), and tolbutamide (Tolinase) may have increased effects, and very low blood sugar levels may result.
Cisapride (Propulsid), which is taken for stomach conditions, as well as antifungal drugs such as ketoconazole (Nizoral), itraconazole (Sporanox), and fluconazole (Diflucan), may increase side effects.
Drugs other than those listed here may also interact with ranitidine bismuth citrate. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines.
Ranitidine bismuth citrate was withdrawn from the U.S. market in 1998.
See also: ranitidine bismuth citrate side effects (in more detail)
Eye Rinderon may be available in the countries listed below.
Betamethasone 21-(disodium phosphate) (a derivative of Betamethasone) is reported as an ingredient of Eye Rinderon in the following countries:
International Drug Name Search